Gemzar and platelet count decreased Patient Reports March 12, 2010

Gemzar Side Effects Report #5068950-3
Gemzar side effect was reported by a Physician from JAPAN on July 12, 2006. Female patient, 75 years of age, weighting 112.0 lb, was diagnosed with urethral cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: abdominal pain upper, blood glucose increased, blood lactate dehydrogenase increased, body temperature decreased, haematocrit decreased, pancreatic duct dilatation, pancreatitis, platelet count decreased, pneumonitis. Gemzar dosage: 2800 MG INTRAVENOUS. During the same period patient was treated with TAXOL, TAXOTERE, NEO MINOPHAGEN C, KYTRIL. Patient recovered.

Gemzar Side Effects Report #5078406-X
Gemzar side effect was reported by a Physician from JAPAN on July 24, 2006. Female patient, 75 years of age, weighting 112.0 lb, was diagnosed with urethral cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood glucose increased, haematocrit decreased, pancreatic duct dilatation, pancreatitis, platelet count decreased, pneumonitis, vulval cancer. Gemzar dosage: 2800 MG, INTRAVENOUS; SEE IMAGE. During the same period patient was treated with TAXOL, TAXOTERE, NEO MINOPHAGEN C, KYTRIL. Patient recovered.

Gemzar Side Effects Report #4641585-X
Gemzar side effect was reported by a Physician from on Apr 06, 2005. Female patient was diagnosed with transitional cell carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haematotoxicity, platelet count decreased. Gemzar dosage: 1000 MG/M2, OTHER. During the same period patient was treated with PACLITAXEL. Patient recovered.

Gemzar Side Effects Report #5328837-5
Gemzar side effect was reported by a Physician from JAPAN on May 09, 2007. Female patient, 55 years of age, was diagnosed with small intestine leiomyosarcoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: granulocyte count decreased, platelet count decreased, tumour haemorrhage. Gemzar dosage: 675 MG/M2, OTHER. During the same period patient was treated with TAXOTERE. Patient recovered.


Gemzar Side Effects Report #5330844-3
Gemzar side effect was reported by a Physician from JAPAN on May 09, 2007. Female patient, 55 years of age, was diagnosed with small intestine leiomyosarcoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: computerised tomogram abnormal, granulocyte count decreased, platelet count decreased, tumour haemorrhage. Gemzar dosage: 675 MG/M2, OTHER. During the same period patient was treated with TAXOTERE. Patient recovered.

Gemzar Side Effects Report #5143591-8
Gemzar side effect was reported by a Physician from JAPAN on Oct 24, 2006. Male patient, 82 years of age, was diagnosed with pancreatic carcinoma stage iv, cerebrovascular accident prophylaxis, trigeminal neuralgia , anorexia, constipation  and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cerebral haemorrhage, international normalised ratio increased, platelet count decreased. Gemzar dosage: 1000 MG, OTHER. During the same period patient was treated with ASPIRIN, NEUROTROPIN, DOGMATYL, SENNOSIDE A, SENNOSIDE A, WARFARIN, HEPARIN. Patient died on 01/01/2006.

Gemzar Side Effects Report #4642562-5
Gemzar side effect was reported by a Physician from on Apr 01, 2005. Male patient, 77 years of age, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, biliary tract infection, condition aggravated, decreased appetite, malignant neoplasm progression, pancreatic carcinoma stage iv, platelet count decreased, white blood cell count decreased. Gemzar dosage: 1000 MG/M2 OTHER. During the same period patient was treated with LOXONIN, SELBEX, LENDORM, URSODIOL, PURSENNID. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5566686-3
Gemzar side effect was reported by a Physician from JAPAN on Dec 13, 2007. Male patient, 75 years of age, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemoglobin decreased, jaundice , jaundice cholestatic, liver disorder, malignant neoplasm progression, platelet count decreased, white blood cell count decreased. Gemzar dosage: unknown. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5879482-4
Gemzar side effect was reported by a Physician from JAPAN on Aug 29, 2008. Female patient, 62 years of age, weighting 114.6 lb, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: myocardial infarction, platelet count decreased. Gemzar dosage: 1400 MG, OTHER. During the same period patient was treated with LOXONIN, MUCOSTA, AMARYL, MAGLAX, OXYCONTIN, NOVAMIN. Patient died on 08/08/2008.


Gemzar Side Effects Report #5860036-0
Gemzar side effect was reported by a Physician from JAPAN on Aug 13, 2008. Female patient, weighting 121.3 lb, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: large intestine perforation, platelet count decreased. Gemzar dosage: 1200 MG, OTHER. Patient died on 06/12/2008.

Gemzar Side Effects Report #6104012-1
Gemzar side effect was reported by a Physician from JAPAN on Mar 02, 2009. Female patient, weighting 105.8 lb, was diagnosed with pancreatic carcinoma stage iv, prophylaxis against gastrointestinal ulcer, constipation , cancer pain and was treated with Gemzar. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, gastric ulcer haemorrhage, metastases to liver, platelet count decreased, shock haemorrhagic, white blood cell count decreased. Gemzar dosage: 1000 MG, OTHER. During the same period patient was treated with PARIET, MAGMITT, FENTANYL, GASMOTIN. Patient died on 01/10/2009.

Gemzar Side Effects Report #5383221-3
Gemzar side effect was reported by a Physician from JAPAN on June 26, 2007. Male patient, 67 years of age, weighting 127.9 lb, was diagnosed with pancreatic carcinoma stage i and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cerebral infarction, flank pain, platelet count decreased, temporal lobe epilepsy, white blood cell count decreased. Gemzar dosage: 1700 MG, OTHER. During the same period patient was treated with DOGMATYL, MEILAX, NORVASC, CYANOCOBALAMIN, EVIPROSTAT, CARNACULIN. Patient recovered.

Gemzar Side Effects Report #5400681-X
Gemzar side effect was reported by a Physician from JAPAN on July 18, 2007. Male patient, 67 years of age, weighting 127.9 lb, was diagnosed with pancreatic carcinoma stage i and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cerebral infarction, flank pain, headache , platelet count decreased, white blood cell count decreased. Gemzar dosage: 1700 MG, OTHER. During the same period patient was treated with DOGMATYL, MEILAX, NORVASC, METHYCOBAL, EVIPROSTAT, CARNACULIN, FAMOTIDINE. Patient recovered.

Gemzar Side Effects Report #6114707-1
Gemzar side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 31, 2008. Male patient, 73 years of age, was diagnosed with pancreatic carcinoma recurrent and was treated with Gemzar. After drug was administered, patient experienced the following side effects: chills, eyelid oedema, leukopenia, neutropenia, oedema peripheral, platelet count decreased. Gemzar dosage: 750 MG/M2. During the same period patient was treated with XELODA, CREON, INSULIN, WARFARIN. Patient recovered.


Gemzar Side Effects Report #6011728-4
Gemzar side effect was reported by a Physician from JAPAN on Dec 11, 2008. Male patient, weighting 101.4 lb, was diagnosed with pancreatic carcinoma recurrent, prophylaxis against gastrointestinal ulcer, benign prostatic hyperplasia, insomnia, hypertension, vitamin b12 deficiency, iron deficiency anaemia and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, arterial thrombosis limb, ascites, cardiac failure, lymphangiosis carcinomatosa, malaise, platelet count decreased, pleural effusion, renal impairment. Gemzar dosage: 1200 MG, OTHER. During the same period patient was treated with GASTER D, HARNAL, MYSLEE, ADALAT, CYANOCOBALAMIN, FESIN. Patient was hospitalized. Patient died on 11/15/2008.

Gemzar Side Effects Report #5709341-9
Gemzar side effect was reported by a Physician from JAPAN on Apr 09, 2008. Female patient, 74 years of age, was diagnosed with pancreatic carcinoma non-resectable and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, deep vein thrombosis , oedema peripheral, platelet count decreased, pyrexia. Gemzar dosage: 1000 MG/M2, OTHER. Patient recovered.

Gemzar Side Effects Report #5725018-8
Gemzar side effect was reported by a Physician from JAPAN on Apr 22, 2008. Female patient, 74 years of age, was diagnosed with pancreatic carcinoma non-resectable and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, deep vein thrombosis , oedema peripheral, platelet count decreased, pyrexia. Gemzar dosage: 1000 MG/M2, OTHER. Patient recovered.

Gemzar Side Effects Report #5418083-9
Gemzar side effect was reported by a Physician from JAPAN on Aug 08, 2007. Male patient, 68 years of age, was diagnosed with pancreatic carcinoma non-resectable and was treated with Gemzar. After drug was administered, patient experienced the following side effects: diabetes mellitus, haemoglobin decreased, platelet count decreased, white blood cell count decreased. Gemzar dosage: 800 MG, OTHER. During the same period patient was treated with THERAPEUTIC RADIOPHARMACEUTICALS. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4928279-8
Gemzar side effect was reported by a Physician from JAPAN on Feb 08, 2006. Female patient, 85 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood bilirubin increased, delirium, platelet count decreased. Gemzar dosage: unknown. Patient recovered.


Gemzar Side Effects Report #4937256-2
Gemzar side effect was reported by a Physician from JAPAN on Feb 16, 2006. Female patient, 85 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood bilirubin increased, delirium, platelet count decreased. Gemzar dosage: unknown. Patient recovered.

Gemzar Side Effects Report #5142479-6
Gemzar side effect was reported by a Physician from JAPAN on Oct 24, 2006. Male patient, 82 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cerebral haemorrhage, platelet count decreased. Gemzar dosage: unknown. Patient died on 01/01/2006.

Gemzar Side Effects Report #5299470-9
Gemzar side effect was reported by a Physician from JAPAN on Apr 11, 2007. Male patient, 79 years of age, weighting 117.7 lb, was diagnosed with pancreatic carcinoma, hepatitis c , hypertension and was treated with Gemzar. After drug was administered, patient experienced the following side effects: liver disorder, melaena, platelet count decreased. Gemzar dosage: 800 MG, OTHER. During the same period patient was treated with THERAPEUTIC RADIOPHARMACEUTICALS, FLUITRAN. Patient died on 10/14/2005.

Gemzar Side Effects Report #4954922-3
Gemzar side effect was reported by a Physician from JAPAN on Mar 10, 2006. Male patient, 79 years of age, weighting 117.7 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, blood urea increased, hepatic failure, hepatic necrosis, international normalised ratio increased, melaena, platelet count decreased. Gemzar dosage: unknown. During the same period patient was treated with THERAPEUTIC RADIOPHARMACEUTICALS, URSO, FLUIRAN. Patient died on 10/14/2005.

Gemzar Side Effects Report #4979629-8
Gemzar side effect was reported by a Physician from JAPAN on Mar 31, 2006. Male patient, 79 years of age, weighting 117.7 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: ammonia increased, blood urea increased, depressed level of consciousness, hepatic failure, hepatic necrosis, liver disorder, melaena, platelet count decreased. Gemzar dosage: unknown. During the same period patient was treated with THERAPEUTIC RADIOPHARMACEUTICALS, URSO, FLUITRAN. Patient died on 10/14/2005.


Gemzar Side Effects Report #5241727-1
Gemzar side effect was reported by a Physician from GERMANY on Feb 09, 2007. Female patient, 76 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood bilirubin increased, blood cholinesterase decreased, blood creatinine increased, haemoglobin decreased, malignant neoplasm progression, platelet count decreased, prothrombin time prolonged, transaminases increased. Gemzar dosage: 1000 MG/M2, UNK. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5521170-8
Gemzar side effect was reported by a Physician from JAPAN on Nov 07, 2007. Male patient, 75 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemoglobin decreased, jaundice , jaundice cholestatic, liver disorder, malignant neoplasm progression, platelet count decreased, white blood cell count decreased. Gemzar dosage: unknown. Patient recovered.

Gemzar Side Effects Report #4614013-8
Gemzar side effect was reported by a Physician from on Feb 25, 2005. Male patient, 73 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: ascites, blood albumin decreased, platelet count decreased, pleural effusion. Gemzar dosage: unknown. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4638387-7
Gemzar side effect was reported by a Physician from on Mar 29, 2005. Male patient, 73 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: ascites, blood albumin decreased, haemoglobin decreased, platelet count decreased, pleural effusion. Gemzar dosage: unknown. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4640694-9
Gemzar side effect was reported by a Physician from on Mar 29, 2005. Male patient, 73 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: ascites, blood albumin decreased, haemoglobin decreased, platelet count decreased, pleural effusion. Gemzar dosage: unknown. Patient was hospitalized. Patient recovered.


Gemzar Side Effects Report #4648421-6
Gemzar side effect was reported by a Physician from on Apr 13, 2005. Male patient, 73 years of age, weighting 125.7 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, asthenia, capillary leak syndrome, hypoalbuminaemia, hypoproteinaemia, oedema, platelet count decreased. Gemzar dosage: 160 MG OTHER. During the same period patient was treated with FOIPAN, BERIZYM, BIOFERMIN, SCOPOLIA, FAMOTIDINE, LOPERAMIDE, HALCION, NAIXAN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4724548-5
Gemzar side effect was reported by a Physician from GERMANY on July 01, 2005. Male patient, 73 years of age, weighting 158.7 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood sodium decreased, cardiac failure, congestive cardiomyopathy, dilatation ventricular, haemoglobin decreased, mitral valve incompetence, platelet count decreased, pleural effusion, ventricular hypokinesia. Gemzar dosage: 1000 MG/M2. During the same period patient was treated with CLOPIDOGREL BISULPHATE, LISINOPRIL, INSULINE. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4776367-1
Gemzar side effect was reported by a Physician from JAPAN on Sept 05, 2005. Male patient, 72 years of age, weighting 154.3 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: biliary tract infection, c-reactive protein increased, condition aggravated, disseminated intravascular coagulation, haemorrhage, international normalised ratio increased, platelet count decreased, prothrombin time prolonged, pyrexia. Gemzar dosage: 200 MG OTHER. During the same period patient was treated with CLINDAMYCIN, ROCEPHIN, MIRACLID, ANTITHROMBIN III. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5485631-2
Gemzar side effect was reported by a Physician from JAPAN on Oct 01, 2007. Male patient, 68 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: condition aggravated, diabetes mellitus, haemoglobin decreased, platelet count decreased, white blood cell count decreased. Gemzar dosage: 800 MG, OTHER. During the same period patient was treated with THERAPEUTIC RADIOPHARMACEUTICALS. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5486380-7
Gemzar side effect was reported by a Physician from JAPAN on Oct 01, 2007. Male patient, 68 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: diabetes mellitus, haemoglobin decreased, platelet count decreased, white blood cell count decreased. Gemzar dosage: 800 MG, OTHER. During the same period patient was treated with THERAPEUTIC RADIOPHARMACEUTICALS. Patient was hospitalized. Patient recovered.


Gemzar Side Effects Report #5048735-4
Gemzar side effect was reported by a Physician from GERMANY on June 22, 2006. Male patient, 65 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, blood creatinine increased, blood lactate dehydrogenase increased, carcinoid tumour, gastric haemorrhage, haemolysis, hypertensive crisis, platelet count decreased, pulmonary oedema. Gemzar dosage: 1000 MG/M2, DAILY (1/D), INTRAVENOUS. During the same period patient was treated with ANTIHYPERTENSIVES, RAMIPRIL, METOPROLOL SUCCINATE, ALDACTONE, DOXAZOSIN, NORVASC. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4710566-X
Gemzar side effect was reported by a Physician from JAPAN on June 22, 2005. Male patient, 65 years of age, weighting 127.9 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: coronary artery stenosis, myocardial infarction, pigmentation disorder, platelet count decreased, platelet count increased. Gemzar dosage: 1600 MG OTHER. During the same period patient was treated with NASEA, URSODIOL, LENDORM, ALESION. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5006531-8
Gemzar side effect was reported by a Physician from GERMANY on May 08, 2006. Male patient, 65 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, blood creatinine increased, blood lactate dehydrogenase increased, gastric haemorrhage, haemolysis, hypertensive crisis, platelet count decreased, pulmonary oedema. Gemzar dosage: 1000 MG/M2, DAILY (1/D), INTRAVENOUS. During the same period patient was treated with ANTIHYPERTENSIVES, RAMIPRIL, METOPROLOL SUCCINATE, ALDACTONE, DOXAZOSIN, NORVASC. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5850788-8
Gemzar side effect was reported by a Physician from JAPAN on Aug 08, 2008. Female patient, 62 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: myocardial infarction, platelet count decreased. Gemzar dosage: 1400 MG, OTHER. During the same period patient was treated with OXYCONTIN, NOVAMIN, AMARYL, LOXONIN, MUCOSTA. Patient died on 08/08/2008.

Gemzar Side Effects Report #6115307-X
Gemzar side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 10, 2008. Female patient, 62 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood creatinine increased, fluid retention, liver disorder, platelet count decreased, red blood cell count decreased, renal impairment. Gemzar dosage: unknown. Patient recovered.


Gemzar Side Effects Report #5383270-5
Gemzar side effect was reported by a Physician from JAPAN on July 04, 2007. Male patient, 61 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cholangitis, hepatic artery occlusion, liver abscess, platelet count decreased, skin disorder. Gemzar dosage: unknown. During the same period patient was treated with FLUOROURACIL, EPIRUBICIN, MITOMYCIN. Patient died on 12/01/2006.

Gemzar Side Effects Report #5383234-1
Gemzar side effect was reported by a Physician from JAPAN on June 29, 2007. Male patient, 59 years of age, weighting 109.3 lb, was diagnosed with pancreatic carcinoma, prophylaxis against gastrointestinal ulcer, back pain , constipation , dyspepsia, prophylaxis of nausea and vomiting and was treated with Gemzar. After drug was administered, patient experienced the following side effects: abdominal pain lower, decreased appetite, hepatic function abnormal, malaise, neutrophil count decreased, platelet count decreased, pyrexia, white blood cell count decreased. Gemzar dosage: 1400 MG, OTHER. During the same period patient was treated with GASTER D, SELTOUCH, MAGLAX, PURSENNID, BERIZYM, NASEA, KYTRIL. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5392239-6
Gemzar side effect was reported by a Physician from JAPAN on July 12, 2007. Male patient, 59 years of age, weighting 109.3 lb, was diagnosed with pancreatic carcinoma, prophylaxis against gastrointestinal ulcer, back pain , constipation , dyspepsia, prophylaxis of nausea and vomiting and was treated with Gemzar. After drug was administered, patient experienced the following side effects: abdominal pain lower, decreased appetite, hepatic function abnormal, malaise, neutrophil count decreased, pancreatitis, platelet count decreased, pyrexia, white blood cell count decreased. Gemzar dosage: unknown. During the same period patient was treated with FAMOTIDINE, SELTOUCH, MAGLAX, PURSENNID, BERIZYM, NASEA, KYTRIL. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5409680-5
Gemzar side effect was reported by a Physician from JAPAN on Aug 02, 2007. Male patient, 59 years of age, weighting 109.3 lb, was diagnosed with pancreatic carcinoma, prophylaxis against gastrointestinal ulcer, back pain , constipation , dyspepsia, prophylaxis of nausea and vomiting and was treated with Gemzar. After drug was administered, patient experienced the following side effects: abdominal pain lower, decreased appetite, hepatic function abnormal, malaise, neutrophil count decreased, pancreatitis, platelet count decreased, pyrexia, white blood cell count decreased. Gemzar dosage: 1300 MG, OTHER. During the same period patient was treated with FAMOTIDINE, SELTOUCH, MAGLAX, PURSENNID, BERIZYM, NASEA, KYTRIL. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5023256-3
Gemzar side effect was reported by a Physician from JAPAN on May 26, 2006. Male patient, 58 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: activities of daily living impaired, gastric ulcer haemorrhage, guillain-barre syndrome , peripheral motor neuropathy, platelet count decreased, respiratory failure, tumour haemorrhage. Gemzar dosage: 1200 MG, OTHER, INTRAVENOUS. During the same period patient was treated with KYTRIL INFUSION, DECADRON, RINDERON, ETODOLAC, PARIET, MUCOSTA, THEOLONG, SPIROPENT. Patient was hospitalized. Patient died on 05/11/2006.

Gemzar Side Effects Report #5778092-7
Gemzar side effect was reported by a Physician from UNITED STATES on June 04, 2008. Male patient, 55 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: disease progression, haemorrhage, hepatic failure, platelet count decreased, pneumonia , renal impairment, sepsis . Gemzar dosage: unknown. During the same period patient was treated with COUMADIN. Patient was hospitalized. Patient died on 06/05/2008.

Gemzar Side Effects Report #4738679-7
Gemzar side effect was reported by a Physician from JAPAN on July 14, 2005. Female patient, 55 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: platelet count decreased, pneumocystis jiroveci pneumonia. Gemzar dosage: 800 MG/M2 OTHER. Patient recovered.

Gemzar Side Effects Report #4870918-4
Gemzar side effect was reported by a Physician from JAPAN on Dec 07, 2005. Male patient, 53 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, bone marrow failure, cardiac failure congestive, hypertensive heart disease, platelet count decreased, pulmonary alveolar haemorrhage. Gemzar dosage: unknown. Patient was hospitalized. Patient died on 10/11/2005.

Gemzar Side Effects Report #5337613-9
Gemzar side effect was reported by a Physician from UNITED STATES on May 18, 2006. Male patient, 50 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: abdominal symptom, disease progression, platelet count decreased. Gemzar dosage: unknown. Patient recovered.

Gemzar Side Effects Report #5133037-8
Gemzar side effect was reported by a Physician from JAPAN on Oct 02, 2006. Female patient, 45 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anti-platelet antibody positive, platelet count decreased. Gemzar dosage: 400 MG/M2, OTHER, INTRAVENOUS. Patient was hospitalized. Patient recovered.


Gemzar Side Effects Report #5290328-8
Gemzar side effect was reported by a Physician from JAPAN on Mar 28, 2007. Female patient was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: c-reactive protein increased, platelet count decreased. Gemzar dosage: 1600 MG, UNK. Patient recovered.

Gemzar Side Effects Report #5388358-0
Gemzar side effect was reported by a Physician from JAPAN on July 05, 2007. Male patient was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, disseminated intravascular coagulation, jaundice , malignant neoplasm progression, platelet count decreased. Gemzar dosage: 1550 MG, OTHER. Patient recovered.

Gemzar Side Effects Report #5786059-8
Gemzar side effect was reported by a Physician from JAPAN on June 12, 2008. Female patient was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, platelet count decreased, renal failure, white blood cell count decreased. Gemzar dosage: 1000 MG, OTHER. During the same period patient was treated with PROTECADIN, WARFARIN, URSO, LOXONIN, STARSIS, PRIMPERAN, ZOFRAN. Patient died on 11/04/2007.

Gemzar Side Effects Report #4992590-5
Gemzar side effect was reported by a Health Professional from UNITED STATES on Sept 21, 2005. Male patient was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: platelet count decreased. Gemzar dosage: 800 MG/M2. Patient recovered.

Gemzar Side Effects Report #4735285-5
Gemzar side effect was reported by a Physician from UNITED STATES on July 19, 2005. Female patient, 88 years of age, was diagnosed with ovarian cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cardiac disorder, chest pain , dyspnoea, hypertension, ischaemia, platelet count decreased, white blood cell count decreased. Gemzar dosage: 1190 MG. During the same period patient was treated with TAXOL, CARBOPLATIN, TAXOTERE. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4737431-6
Gemzar side effect was reported by a Physician from UNITED STATES on July 19, 2005. Female patient, 88 years of age, was diagnosed with ovarian cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cardiac disorder, chest pain , dyspnoea, hypertension, ischaemia, platelet count decreased, white blood cell count decreased. Gemzar dosage: 1190 MG. During the same period patient was treated with TAXOL, CARBOPLATIN, TAXOTERE. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4714603-8
Gemzar side effect was reported by a Health Professional from UNITED STATES on July 14, 2005. Female patient, 74 years of age, weighting 145.5 lb, was diagnosed with ovarian cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: chills, feeling abnormal, haemoglobin decreased, neutropenia, platelet count decreased, pyrexia, white blood cell count decreased. Gemzar dosage: unknown. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5475974-0
Gemzar side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 24, 2007. Female patient, 50 years of age, weighting 140.0 lb, was diagnosed with ovarian cancer, insomnia, headache  and was treated with Gemzar. After drug was administered, patient experienced the following side effects: fatigue, muscle spasms, pain , platelet count decreased, platelet count increased. Gemzar dosage: 1200 MG, OTHER. During the same period patient was treated with ATIVAN, ADVIL. Patient recovered.

Gemzar Side Effects Report #5224299-7
Gemzar side effect was reported by a Physician from FINLAND on Jan 23, 2007. Female patient, 46 years of age, was diagnosed with ovarian cancer, pain , pulmonary embolism  and was treated with Gemzar. After drug was administered, patient experienced the following side effects: platelet count decreased, pyrexia, urticaria. Gemzar dosage: unknown. During the same period patient was treated with DUROGESIC, CARBOPLATIN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5191793-7
Gemzar side effect was reported by a Physician from FINLAND on Dec 18, 2006. Female patient, 46 years of age, was diagnosed with ovarian cancer, pain , pulmonary embolism  and was treated with Gemzar. After drug was administered, patient experienced the following side effects: platelet count decreased, pyrexia, urticaria. Gemzar dosage: unknown. During the same period patient was treated with DUROGESIC. Patient was hospitalized. Patient recovered.


Gemzar Side Effects Report #4655325-1
Gemzar side effect was reported by a Health Professional from on Apr 15, 2005. Male patient, 73 years of age, was diagnosed with non-small cell lung cancer stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: asthenia, coombs positive haemolytic anaemia, gastrointestinal haemorrhage, platelet count decreased, procedural complication, white blood cell count decreased. Gemzar dosage: 200 MG/M2. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5215584-3
Gemzar side effect was reported by a Physician from IRELAND on Jan 15, 2007. Female patient, 65 years of age, was diagnosed with non-small cell lung cancer stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: platelet count decreased, pulmonary embolism . Gemzar dosage: 1200 MG/M2, UNK. During the same period patient was treated with CARBOPLATIN. Patient recovered.

Gemzar Side Effects Report #5219359-0
Gemzar side effect was reported by a Physician from IRELAND on Jan 15, 2007. Female patient, 65 years of age, was diagnosed with non-small cell lung cancer stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood count abnormal, platelet count decreased, pulmonary embolism . Gemzar dosage: 1200 MG/M2, UNK. During the same period patient was treated with CARBOPLATIN. Patient recovered.

Gemzar Side Effects Report #5337434-7
Gemzar side effect was reported by a Physician from UNITED STATES on Sept 25, 2006. Female patient, 62 years of age, weighting 121.9 lb, was diagnosed with non-small cell lung cancer stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haematocrit decreased, haemoglobin decreased, platelet count decreased, red blood cell count decreased, white blood cell count decreased. Gemzar dosage: 1000 MG/M2, OTHER, INTRAVENOUS. During the same period patient was treated with CARBOPLATIN, PREDNISONE, PREVACID, PROCHLORPERAZINE MALEATE, TRAMADOL, PERSANTINE, PREGABALIN. Patient recovered.

Gemzar Side Effects Report #5087095-X
Gemzar side effect was reported by a Health Professional from TURKEY on Aug 01, 2006. Male patient, 61 years of age, weighting 154.3 lb, was diagnosed with non-small cell lung cancer stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: bone marrow toxicity, dyspnoea, haemoglobin decreased, loss of consciousness, neutrophil percentage decreased, platelet count decreased, white blood cell count decreased. Gemzar dosage: 1800 MG, OTHER, INTRAVENOUS. During the same period patient was treated with CISPLATIN, ANTIEMETICS AND ANTINAUSEANTS, ANTIHISTAMINES, CORTICOSTEROIDS. Patient was hospitalized. Patient died on 03/11/2004.

Gemzar Side Effects Report #4853514-4
Gemzar side effect was reported by a Physician from JAPAN on Nov 24, 2005. Female patient, 59 years of age, weighting 97.00 lb, was diagnosed with non-small cell lung cancer stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anorexia, c-reactive protein increased, platelet count decreased, pneumonia , pyrexia, white blood cell count decreased. Gemzar dosage: 1300 MG, OTHER, INTRAVENOUS. During the same period patient was treated with CARBOPLATIN, ORGADRONE, NASEA. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5263912-5
Gemzar side effect was reported by a Physician from IRELAND on Feb 28, 2007. Female patient, 54 years of age, weighting 154.3 lb, was diagnosed with non-small cell lung cancer stage iv, insomnia and was treated with Gemzar. After drug was administered, patient experienced the following side effects: neutrophil count decreased, platelet count decreased, pulmonary embolism . Gemzar dosage: 1200 MG/M2, UNK. During the same period patient was treated with CARBOPLATIN, ESOMEPRAZOLE MAGNESIUM, ZOPICLONE, PROPYLTHIOURACIL, MESULID. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5708121-8
Gemzar side effect was reported by a Physician from JAPAN on Apr 07, 2008. Male patient, weighting 83.78 lb, was diagnosed with non-small cell lung cancer stage iiib and was treated with Gemzar. After drug was administered, patient experienced the following side effects: abdominal pain , anaemia, anxiety , decreased appetite, platelet count decreased. Gemzar dosage: 1000 MG, OTHER. During the same period patient was treated with CARBOPLATIN, GASTER D, LASIX, ASPARA K, TOLEDOMIN. Patient died on 09/27/2005.

Gemzar Side Effects Report #5966096-0
Gemzar side effect was reported by a Physician from UNITED STATES on Nov 13, 2008. Female patient, weighting 149.0 lb, was diagnosed with non-small cell lung cancer stage ii and was treated with Gemzar. After drug was administered, patient experienced the following side effects: diabetic neuropathy, glomerulosclerosis, haemolytic uraemic syndrome, nephrosclerosis, platelet count decreased, renal failure acute, renal failure chronic, thrombotic microangiopathy, tubulointerstitial nephritis. Gemzar dosage: unknown. During the same period patient was treated with CARBOPLATIN, ADALAT, AVAPRO, VITAMIN B, FISH OIL, GLUCOPHAGE, YEAST. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4813399-9
Gemzar side effect was reported by a Physician from JAPAN on Oct 06, 2005. Male patient, 82 years of age, weighting 83.78 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: abdominal pain , anaemia, anxiety , decreased appetite, platelet count decreased. Gemzar dosage: 1000 MG OTHER. During the same period patient was treated with CARBOPLATIN, GASTER D, LASIX, ASPARA K, TOLEDOMIN. Patient died on 09/27/2005.


Gemzar Side Effects Report #5646915-8
Gemzar side effect was reported by a Physician from UNITED STATES on Feb 24, 2008. Male patient, 75 years of age, weighting 185.0 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, dyspnoea, platelet count decreased, pneumonia , white blood cell count decreased. Gemzar dosage: unknown. During the same period patient was treated with TARCEVA, INSPRA, COREG, DIABETA, ZOCOR. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5337810-2
Gemzar side effect was reported by a Physician from UNITED STATES on Jan 11, 2006. Male patient, 74 years of age, weighting 179.9 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, dyspnoea, haemoglobin decreased, platelet count decreased, platelet count increased, pulmonary toxicity, white blood cell count decreased, white blood cell count increased. Gemzar dosage: unknown. Patient recovered.

Gemzar Side Effects Report #4992605-4
Gemzar side effect was reported by a Health Professional from UNITED STATES on Jan 11, 2006. Male patient, 74 years of age, weighting 179.9 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, dyspnoea, haematocrit decreased, haemoglobin decreased, platelet count decreased, platelet count increased, pulmonary toxicity, white blood cell count decreased, white blood cell count increased. Gemzar dosage: 1800 MG. Patient recovered.

Gemzar Side Effects Report #5337816-3
Gemzar side effect was reported by a Physician from UNITED STATES on Jan 16, 2006. Female patient, 73 years of age, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: platelet count decreased. Gemzar dosage: 1000 MG/M2. During the same period patient was treated with CARBOPLATIN. Patient recovered.

Gemzar Side Effects Report #6115275-0
Gemzar side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 29, 2008. Male patient, 72 years of age, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood count abnormal, haemoglobin decreased, lacrimation increased, ocular hyperaemia, paraesthesia, platelet count decreased, vomiting, white blood cell count decreased. Gemzar dosage: 1000 MG/M2. During the same period patient was treated with NEXIUM, ANTIHYPERTENSIVES. Patient recovered.

Gemzar Side Effects Report #4579432-7
Gemzar side effect was reported by a Physician from on Jan 24, 2005. Female patient, 69 years of age, weighting 191.8 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haematocrit decreased, haemoglobin decreased, platelet count decreased, pruritus, stridor, white blood cell count decreased. Gemzar dosage: 1600 MG. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4799893-8
Gemzar side effect was reported by a Physician from JAPAN on Sept 28, 2005. Male patient, 66 years of age, weighting 143.3 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: platelet count decreased, pneumonia , white blood cell count decreased. Gemzar dosage: unknown. During the same period patient was treated with CISPLATIN. Patient died on 09/21/2005.

Gemzar Side Effects Report #4806816-1
Gemzar side effect was reported by a Physician from CHINA on Sept 28, 2005. Male patient, 66 years of age, weighting 149.9 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: platelet count decreased, pneumonia , pulmonary haemorrhage, respiratory failure, white blood cell count decreased. Gemzar dosage: unknown. During the same period patient was treated with CISPLATIN, CARBOPLATIN, CEFOPERAZONE W. Patient died on 09/21/2005.

Gemzar Side Effects Report #4814950-5
Gemzar side effect was reported by a Physician from CHINA on Oct 11, 2005. Male patient, 66 years of age, weighting 149.9 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: platelet count decreased, pneumonia , pulmonary haemorrhage, respiratory failure, white blood cell count decreased. Gemzar dosage: unknown. During the same period patient was treated with CISPLATIN, CARBOPLATIN, CEFOPERAZONE W. Patient died on 09/21/2005.

Gemzar Side Effects Report #5033874-4
Gemzar side effect was reported by a Physician from UNITED STATES on June 07, 2006. Male patient, 62 years of age, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: arthritis , cyanosis, fluid retention, hepatic enzyme increased, platelet count decreased, renal failure. Gemzar dosage: 1000 MG/M2,. During the same period patient was treated with CARBOPLATIN, DECADRON, ALOXIPRIN. Patient was hospitalized. Patient recovered.


Gemzar Side Effects Report #5700424-6
Gemzar side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 01, 2008. Male patient, 59 years of age, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cough, fall , hypotension, platelet count decreased, rib fracture. Gemzar dosage: unknown. During the same period patient was treated with DEXAMETHASONE. Patient recovered.

Gemzar Side Effects Report #4937093-9
Gemzar side effect was reported by a Consumer or non-health professional from AUSTRIA on Feb 20, 2006. Male patient, 57 years of age, weighting 198.4 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, dialysis , haemodialysis, haptoglobin decreased, nephritis interstitial, platelet count decreased. Gemzar dosage: unknown. During the same period patient was treated with CISPLATIN, TAXOTERE, NORMOXIN, NORVASC, AQUAPHORIL, NEXIUM, MUCOBENE, OXIS TURBUHALER. Patient was hospitalized and became disabled. Patient recovered.

Gemzar Side Effects Report #5371730-2
Gemzar side effect was reported by a Physician from GERMANY on June 20, 2007. Male patient, 56 years of age, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, mucosal haemorrhage, nausea , pancytopenia, platelet count decreased, platelet count increased, pyrexia, renal failure, renal impairment. Gemzar dosage: 1000 MG/M2, UNK. During the same period patient was treated with ALIMTA, CISPLATIN, VITAMIN B, FOLSAEURE, DEXAMETHASONE, ZOMETA. Patient was hospitalized and became disabled. Patient died on 01/01/2007.

Gemzar Side Effects Report #4788903-X
Gemzar side effect was reported by a Physician from UNITED STATES on Sept 21, 2005. Male patient, 54 years of age, weighting 176.4 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: constipation , gastritis, oesophagitis, platelet count decreased, retinal artery occlusion, retinal exudates, retinal haemorrhage, retinal vascular disorder, retinopathy. Gemzar dosage: 1400 MG OTHER. During the same period patient was treated with PARAPLATIN, KYTRILL, FAMOTIDINE, NIVADIL, DOXAZOSIN MESYLATE, LOXONIN, SOSEGON, OXYCONTIN. Patient recovered.

Gemzar Side Effects Report #4806703-9
Gemzar side effect was reported by a Physician from JAPAN on Oct 03, 2005. Male patient, 54 years of age, weighting 176.4 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: constipation , gastric ulcer, gastritis, insomnia, oesophagitis, platelet count decreased, retinal artery occlusion, retinal exudates, retinal haemorrhage. Gemzar dosage: 1400 MG OTHER. During the same period patient was treated with PARAPLATIN, KYTRIL, FAMOTIDINE, NIVADIL, DOXAZOSIN MESYLATE, LOXONIN, SOSEGON, OXYCONTIN. Patient recovered.

Gemzar Side Effects Report #5749847-X
Gemzar side effect was reported by a Consumer or non-health professional from UNITED STATES on May 20, 2008. Male patient, weighting 241.2 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cough, fall , hypotension, platelet count decreased, rib fracture. Gemzar dosage: unknown. During the same period patient was treated with DEXAMETHASONE. Patient recovered.

Gemzar Side Effects Report #4777635-X
Gemzar side effect was reported by a Physician from UNITED STATES on Sept 01, 2005. Male patient was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: gastrointestinal haemorrhage, platelet count decreased. Gemzar dosage: 1000 MG. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5951775-1
Gemzar side effect was reported by a Physician from UNITED STATES on Nov 04, 2008. Male patient, 84 years of age, was diagnosed with metastatic carcinoma of the bladder and was treated with Gemzar. After drug was administered, patient experienced the following side effects: platelet count decreased, thrombotic thrombocytopenic purpura. Gemzar dosage: unknown. During the same period patient was treated with CARBOPLATIN. Patient recovered.

Gemzar Side Effects Report #4680543-6
Gemzar side effect was reported by a Physician from on May 13, 2005. Male patient, 48 years of age, weighting 163.1 lb, was diagnosed with metastatic bronchial carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: asthenia, cough, crepitations, haemoglobin decreased, neutrophil count decreased, platelet count decreased, purpura, pyrexia, red blood cell count decreased. Gemzar dosage: unknown. During the same period patient was treated with CISPLATIN, DEPAKENE, URBANYL, IMUDON, NEURONTIN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5261053-4
Gemzar side effect was reported by a Physician from JAPAN on Feb 28, 2007. Male patient, 60 years of age, was diagnosed with malignant neoplasm of renal pelvis and was treated with Gemzar. After drug was administered, patient experienced the following side effects: gastrointestinal disorder, platelet count decreased. Gemzar dosage: 1000 MG/M2, OTHER. During the same period patient was treated with CISPLATIN. Patient recovered.

Gemzar Side Effects Report #4639083-2
Gemzar side effect was reported by a Physician from on Mar 29, 2005. Male patient, 79 years of age, weighting 134.5 lb, was diagnosed with lung neoplasm malignant and was treated with Gemzar. After drug was administered, patient experienced the following side effects: eczema , eosinophil percentage increased, epistaxis, hypersensitivity, interstitial lung disease, neutrophil count decreased, platelet count decreased, vasculitis , white blood cell count decreased. Gemzar dosage: 1670 MG OTHER. During the same period patient was treated with NAVELBINE, SELBEX, MOBIC, FERROMIA, LOXOPROFEN, FAMOTIDINE. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4640629-9
Gemzar side effect was reported by a Physician from on Mar 29, 2005. Male patient, 79 years of age, weighting 134.5 lb, was diagnosed with lung neoplasm malignant and was treated with Gemzar. After drug was administered, patient experienced the following side effects: eczema , eosinophil count increased, epistaxis, hypersensitivity, interstitial lung disease, neutrophil count decreased, platelet count decreased, vasculitis , white blood cell count decreased. Gemzar dosage: 1670 MG OTHER. During the same period patient was treated with NAVELBINE, SELBEX, MOBIC, FERROMIA, LOXOPROFEN, FAMOTIDINE. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4832715-5
Gemzar side effect was reported by a Physician from SPAIN on Nov 09, 2005. Female patient, 59 years of age, weighting 185.2 lb, was diagnosed with lung neoplasm malignant and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, metrorrhagia, neutropenia, platelet count decreased. Gemzar dosage: 1250 MG/M2/2 OTHER. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5022548-1
Gemzar side effect was reported by a Physician from JAPAN on May 24, 2006. Male patient, 59 years of age, was diagnosed with lung neoplasm malignant and was treated with Gemzar. After drug was administered, patient experienced the following side effects: platelet count decreased, platelet count increased. Gemzar dosage: unknown. During the same period patient was treated with NAVELBINE. Patient recovered.

Gemzar Side Effects Report #5278039-6
Gemzar side effect was reported by a Consumer or non-health professional from BRAZIL on Mar 19, 2007. Female patient, 67 years of age, was diagnosed with lung cancer metastatic, lung neoplasm malignant and was treated with Gemzar. After drug was administered, patient experienced the following side effects: bone cancer metastatic, bone pain, brain cancer metastatic, platelet count decreased, pyrexia, white blood cell count decreased. Gemzar dosage: unknown. During the same period patient was treated with DEXAMETHASONE, NAUSEDRON. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5878937-6
Gemzar side effect was reported by a Physician from JAPAN on Aug 28, 2008. Male patient, 64 years of age, weighting 103.6 lb, was diagnosed with lung adenocarcinoma stage iv, prophylaxis and was treated with Gemzar. After drug was administered, patient experienced the following side effects: arteritis, cough, disseminated intravascular coagulation, local swelling, malaise, multi-organ failure, platelet count decreased, pneumonia , pyrexia. Gemzar dosage: 1400 MG, OTHER. During the same period patient was treated with PARAPLATIN, DECADRON, KYTRIL. Patient died on 07/12/2008.

Gemzar Side Effects Report #4992734-5
Gemzar side effect was reported by a Pharmacist from UNITED STATES on May 23, 2005. Female patient, 77 years of age, was diagnosed with hepatic neoplasm malignant and was treated with Gemzar. After drug was administered, patient experienced the following side effects: platelet count decreased, rash . Gemzar dosage: 1640 MG, INTRAVENOUS. During the same period patient was treated with XELODA. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4992793-X
Gemzar side effect was reported by a Physician from UNITED STATES on Oct 28, 2005. Male patient, 60 years of age, was diagnosed with gastric cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: platelet count decreased, white blood cell count decreased. Gemzar dosage: 1600 MG. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5520491-2
Gemzar side effect was reported by a Physician from JAPAN on Nov 06, 2007. Female patient, weighting 106.9 lb, was diagnosed with gallbladder cancer stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood albumin decreased, haemoglobin decreased, hepatic function abnormal, malignant neoplasm progression, neutrophil count decreased, platelet count decreased, po2 decreased, white blood cell count decreased. Gemzar dosage: 1400 MG, OTHER. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5371734-X
Gemzar side effect was reported by a Physician from JAPAN on June 18, 2007. Male patient, 81 years of age, weighting 85.98 lb, was diagnosed with gallbladder cancer recurrent and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemoglobin decreased, interstitial lung disease, platelet count decreased. Gemzar dosage: 1000 MG/M2, UNK. During the same period patient was treated with HARNAL, SENNOSIDE A, LEUCON. Patient was hospitalized. Patient died on 06/13/2007.

Gemzar Side Effects Report #4790488-9
Gemzar side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 19, 2005. Female patient was diagnosed with colon cancer metastatic, metastases to fallopian tube and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anorexia, crying, fatigue, feeling abnormal, platelet count decreased, renal failure, somnolence. Gemzar dosage: 2200 MG. During the same period patient was treated with CARBOPLATIN, NEULASTA, KYTRIL, DECADRON. Patient was hospitalized. Patient recovered.